KATHY BRINKMAN: Open Payments
NPI 1750326906 · MONROE CITY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,882 in 111 payments from 23 companies in 2025. Trend: 2023 $2,030 · 2024 $1,895 · 2025 $1,882
Food & beverage: $1,882
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $354 |
| Novo Nordisk Inc | 20 | $325 |
| PFIZER INC. | 11 | $167 |
| AstraZeneca Pharmaceuticals LP | 5 | $157 |
| Merck Sharp & Dohme LLC | 7 | $125 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 5 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $66 |
| Viatris Specialty LLC | 3 | $58 |
Products named: UBRELVY, Ozempic, VERQUVO, AIRSUPRA, QULIPTA, REXULTI, Kerendia, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
